Literature DB >> 22186994

CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.

Brenda A Finney1, Edina Schweighoffer, Leyre Navarro-Núñez, Cecile Bénézech, Francesca Barone, Craig E Hughes, Stacey A Langan, Kate L Lowe, Alice Y Pollitt, Diego Mourao-Sa, Steve Sheardown, Gerard B Nash, Nicholas Smithers, Caetano Reis e Sousa, Victor L J Tybulewicz, Steve P Watson.   

Abstract

The C-type lectin receptor CLEC-2 signals through a pathway that is critically dependent on the tyrosine kinase Syk. We show that homozygous loss of either protein results in defects in brain vascular and lymphatic development, lung inflation, and perinatal lethality. Furthermore, we find that conditional deletion of Syk in the hematopoietic lineage, or conditional deletion of CLEC-2 or Syk in the megakaryocyte/platelet lineage, also causes defects in brain vascular and lymphatic development, although the mice are viable. In contrast, conditional deletion of Syk in other hematopoietic lineages had no effect on viability or brain vasculature and lymphatic development. We show that platelets, but not platelet releasate, modulate the migration and intercellular adhesion of lymphatic endothelial cells through a pathway that depends on CLEC-2 and Syk. These studies found that megakaryocyte/platelet expression of CLEC-2 and Syk is required for normal brain vasculature and lymphatic development and that platelet CLEC-2 and Syk directly modulate lymphatic endothelial cell behavior in vitro.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186994      PMCID: PMC3351942          DOI: 10.1182/blood-2011-09-380709

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Polarized migration of lymphatic endothelial cells is critically dependent on podoplanin regulation of Cdc42.

Authors:  Angels Navarro; Ricardo E Perez; Mohammad H Rezaiekhaligh; Sherry M Mabry; Ikechukwu I Ekekezie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

2.  The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.

Authors:  J C Spalton; J Mori; A Y Pollitt; C E Hughes; J A Eble; S P Watson
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

3.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

4.  Pulmonary lymph flow and the uptake of liquid from the lungs of the lamb at the start of breathing.

Authors:  P W Humphreys; I C Normand; E O Reynolds; L B Strang
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

5.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

Authors:  T Mäkinen; T Veikkola; S Mustjoki; T Karpanen; B Catimel; E C Nice; L Wise; A Mercer; H Kowalski; D Kerjaschki; S A Stacker; M G Achen; K Alitalo
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

6.  CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.

Authors:  Frauke May; Ina Hagedorn; Irina Pleines; Markus Bender; Timo Vögtle; Johannes Eble; Margitta Elvers; Bernhard Nieswandt
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

7.  Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.

Authors:  Xiaodong Xie; Rebecca J Chan; Scott A Johnson; Mark Starr; Jennifer McCarthy; Reuben Kapur; Mervin C Yoder
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

8.  Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk.

Authors:  Farhad Abtahian; Anastasia Guerriero; Eric Sebzda; Min-Min Lu; Rong Zhou; Attila Mocsai; Erin E Myers; Bin Huang; David G Jackson; Victor A Ferrari; Victor Tybulewicz; Clifford A Lowell; John J Lepore; Gary A Koretzky; Mark L Kahn
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

9.  CLEC-2 activates Syk through dimerization.

Authors:  Craig E Hughes; Alice Y Pollitt; Jun Mori; Johannes A Eble; Michael G Tomlinson; John H Hartwig; Christopher A O'Callaghan; Klaus Fütterer; Steve P Watson
Journal:  Blood       Date:  2010-02-12       Impact factor: 22.113

10.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre.

Authors:  Jasper de Boer; Adam Williams; George Skavdis; Nicola Harker; Mark Coles; Mauro Tolaini; Trisha Norton; Keith Williams; Kathleen Roderick; Alexandre J Potocnik; Dimitris Kioussis
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

View more
  55 in total

1.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  Lin28b regulates age-dependent differences in murine platelet function.

Authors:  Massiel Chavez Stolla; Seana C Catherman; Paul D Kingsley; R Grant Rowe; Anne D Koniski; Katherine Fegan; Leah Vit; Kathleen E McGrath; George Q Daley; James Palis
Journal:  Blood Adv       Date:  2019-01-08

3.  Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Authors:  Kate L Lowe; Brenda A Finney; Carsten Deppermann; René Hägerling; Salomé L Gazit; Jon Frampton; Christopher Buckley; Eric Camerer; Bernhard Nieswandt; Friedemann Kiefer; Steve P Watson
Journal:  Blood       Date:  2015-04-23       Impact factor: 22.113

4.  SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.

Authors:  Gerald Moncayo; Michal Grzmil; Tatiana Smirnova; Pawel Zmarz; Roland M Huber; Debby Hynx; Hubertus Kohler; Yuhua Wang; Hans-Rudolf Hotz; Nancy E Hynes; Georg Keller; Stephan Frank; Adrian Merlo; Brian A Hemmings
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

5.  Proteasome function is required for platelet production.

Authors:  Dallas S Shi; Matthew C P Smith; Robert A Campbell; Patrick W Zimmerman; Zechariah B Franks; Bjorn F Kraemer; Kellie R Machlus; Jing Ling; Patrick Kamba; Hansjörg Schwertz; Jesse W Rowley; Rodney R Miles; Zhi-Jian Liu; Martha Sola-Visner; Joseph E Italiano; Hilary Christensen; Walter H A Kahr; Dean Y Li; Andrew S Weyrich
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

Review 6.  Adoptive transfer method to study platelet function in mouse models of disease.

Authors:  Wolfgang Bergmeier; Yacine Boulaftali
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 7.  Blood and lymphatic vessel formation.

Authors:  Victoria L Bautch; Kathleen M Caron
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-03-02       Impact factor: 10.005

Review 8.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

9.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

10.  Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.

Authors:  Jessica R Hitchcock; Charlotte N Cook; Saeeda Bobat; Ewan A Ross; Adriana Flores-Langarica; Kate L Lowe; Mahmood Khan; C Coral Dominguez-Medina; Sian Lax; Manuela Carvalho-Gaspar; Stefan Hubscher; G Ed Rainger; Mark Cobbold; Christopher D Buckley; Tim J Mitchell; Andrea Mitchell; Nick D Jones; N Van Rooijen; Daniel Kirchhofer; Ian R Henderson; David H Adams; Steve P Watson; Adam F Cunningham
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.